Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
SMINT: Stage 2 application FP7-HEALTH-13-INNOVATION-1. Novel targets for cardiovascular disease treatment.
| Reference number | 2012-04514 |
| Coordinator | RED GLEAD DISCOVERY AB |
| Funding from Vinnova | SEK 118 983 |
| Project duration | December 2012 - February 2013 |
| Status | Completed |
Last updated 25 November 2019
Reference number 2012-04514
